Looks like Kintor finished enrollment and dosing of phase 1 for gt20029 in China.
    Chat 8/9/2022

    The conversation discusses the potential of a new hair loss treatment, GT20029, which targets androgen receptors in the scalp and is in phase 1 trials in China. Users express hope that this treatment will be more effective than current options like Minoxidil and Finasteride.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 218 results

    Related Research

    5 / 5 results